← All medicines
Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)
Licence EU/1/21/1612/001-006 · Unknown
- Licence holder
- Pfizer Europe MA EEIG (all products →)
- Active substances
- Pneumococcal polysaccharide serotype 1, Pneumococcal Polysaccharide Serotype 3, Pneumococcal polysaccharide serotype 4, Pneumococcal polysaccharide serotype 5, Pneumococcal Polysaccharide Serotype 6A, Pneumococcal polysaccharide serotype 7f, Pneumococcal Polysaccharide Serotype 8, Pneumococcal polysaccharide serotype 9v, Pneumococcal Polysaccharide Serotype 10A, Pneumococcal Polysaccharide Serotype 11A, Pneumococcal Polysaccharide Serotype 12F, Pneumococcal polysaccharide serotype 14, Pneumococcal Polysaccharide Serotype 15B, Pneumococcal polysaccharide serotype 18c, Pneumococcal Polysaccharide Serotype 19A, Pneumococcal polysaccharide serotype 19f, Pneumococcal Polysaccharide Serotype 22F, Pneumococcal polysaccharide serotype 23f, Pneumococcal Polysaccharide Serotype 33F
- Dosage form
- Suspension for injection
- Route of administration
- Intramuscular use
- ATC code
- J07AL02
- First authorised
- 14/02/2022
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.